Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5734-5742

  Shair, Kathy H Y ^a   Schnegg, Caroline I ^a   Raab Traub, Nancy ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; LATENT MEMBRANE PROTEIN 1; LYMPHOID ENHANCER FACTOR 1; NERVE CELL ADHESION MOLECULE; PHOSPHATIDYLINOSITOL 3 KINASE; PLAKOGLOBIN; PROTEIN KINASE B; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER GROWTH; CELL JUNCTION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STABILITY; TUMOR BIOPSY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADHERENS JUNCTIONS; BETA CATENIN; BIOPSY; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; GAMMA CATENIN; HUMANS; IMMUNOBLOTTING; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL MATRIX PROTEINS;

EID: 67651006731     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0468     Document Type: Article

References (45)

1. Raab-Traub N. Pathogenesis of Epstein-Barr virus and its associated malignancies. Semin Virol 1996;7:315-23.
2. Rickinson A, Kieff E. Epstein-Barr Virus and Its Replication. In: Knipe ID, editor. Field's Virology. 4th ed. Philadelphia (PA): Lippincott Williams & Wilkins Publishers; 2001. p. 2511-73.
3. Mainou BA, Everly DN, Jr., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 2005;24:6917-24.
4. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985;43:831-40.
5. Kulwichit W, Edwards RH, Davenport EM, Baskar JF, Godfrey V, Raab-Traub N. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A 1998;95:11963-8.
6. Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990;61:1315-27.
7. Lu J, Lin WH, Chen SY, et al. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. J Biol Chem 2006;281:8806-14.
8. Morrison JA, Klingelhutz AJ, Raab-Traub N. Epstein-Barr virus latent membrane protein 2A activates β-catenin signaling in epithelial cells. J Virol 2003;77:12276-84.
9. Pegtel DM, Subramanian A, Sheen TS, Tsai CH, Golub TR, Thorley-Lawson DA. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol 2005;79:15430-42.
10. Scholle F, Bendt KM, Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 2000;74: 10681-9.
11. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 2008;82:3654-64.
12. Eliopoulos AG, Young LS. LMP1 structure and signal transduction. Semin Cancer Biol 2001;11:435-44.
13. Everly DN, Jr., Mainou BA, Raab-Traub N. The ID proteins contribute to the growth of rodent fibroblasts during LMP1-mediated transformation. Virology 2008; 376:258-69.
14. Mainou BA, Everly DN, Jr., Raab-Traub N. Unique signaling properties of CTAR1 in LMP1-mediated transformation. J Virol 2007;81:9680-92.
15. Paine E, Scheinman RI, Baldwin AS, Jr., Raab-Traub N. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-κB/Rel family proteins. J Virol 1995;69:4572-6.
16. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-41.
17. Kondo S, Yoshizaki T, Wakisaka N, et al. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. J Virol 2007;81: 1554-62.
18. Tsao SW, Tramoutanis G, Dawson CW, Lo AK, Huang DP. The significance of LMP1 expression in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:473-87.
19. Shair KH, Bendt KM, Edwards RH, Bedford EC, Nielsen JN, Raab-Traub N. EBV latent membrane protein 1 activates Akt, NFκB, and Stat3 in B cell lymphomas. PLoS Pathog 2007;3:e166.
20. Shair KH, Schnegg CI, Raab-Traub N. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res 2008;68:6997-7005.
21. Bierkamp C, Schwarz H, Huber O, Kemler R. Desmosomal localization of β-catenin in the skin of plakoglobin null-mutant mice. Development 1999;126: 371-81.
22. Yin T, Green KJ. Regulation of desmosome assembly and adhesion. Semin Cell Dev Biol 2004;15:665-77.
23. Everly DN, Jr., Kusano S, Raab-Traub N. Accumulation of cytoplasmic β-catenin and nuclear glycogen synthase kinase 3β in Epstein-Barr virus-infected cells. J Virol 2004;78:11648-55.
24. Jang KL, Shackelford J, Seo SY, Pagano JS. Up-regulation of β-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc Natl Acad Sci U S A 2005;102:18431-6.
25. Morrison JA, Gulley ML, Pathmanathan R, Raab-Traub N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 2004;64:5251-60.
26. Thornburg NJ, Kusano S, Raab-Traub N. Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. J Virol 2004;78:12848-56.
27. Norvell SM, Green KJ. Contributions of extracellular and intracellular domains of full length and chimeric cadherin molecules to junction assembly in epithelial cells. J Cell Sci 1998;111:1305-18.
28. Everly DN, Jr., Mainou BA, Raab-Traub N. Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation. J Virol 2004; 78:13470-8.
29. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797-804.
30. Salomon D, Sacco PA, Roy SG, et al. Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. J Cell Biol 1997;139:1325-35.
31. Shekhar MP, Gerard B, Pauley RJ, Williams BO, Tait L. Rad6B is a positive regulator of β-catenin stabilization. Cancer Res 2008;68:1741-50.
32. Kolligs FT, Kolligs B, Hajra KM, et al. γ-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin. Genes Dev 2000;14:1319-31.
33. Maeda O, Usami N, Kondo M, et al. Plakoglobin (γ-catenin) has TCF/LEF family-dependent transcriptional activity in β-catenin-deficient cell line. Oncogene 2004; 23:964-72.
34. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 2002;99:10084-9.
35. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann N Y Acad Sci 2004;1014:155-63.
36. Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Ze'ev A. Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin. J Cell Biol 1996;133:199-209.
37. Kim KR, Yoshizaki T, Miyamori H, et al. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Oncogene 2000;19:1764-71.
38. Yin T, Getsios S, Caldelari R, et al. Plakoglobin suppresses keratinocyte motility through both cell-cell adhesion-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 2005;102:5420-5.
39. Yin T, Getsios S, Caldelari R, et al. Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem 2005;280:40355-63.
40. Ferber EC, Kajita M, Wadlow A, et al. A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus. J Biol Chem 2008;283:12691-700.
41. Winn RA, Bremnes RM, Bemis L, et al. γ-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growth. Oncogene 2002;21:7497-506.
42. Horikawa T, Yang J, Kondo S, et al. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 2007;67:1970-8.
43. Chidgey M, Dawson C. Desmosomes: a role in cancer? Br J Cancer 2007;96:1783-7.
44. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996; 135:1643-54.
45. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. Ncadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999; 147:631-44.